Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $77,344 | $87,721 | $119,394 | $64,696 |
| Short-Term Investments | $251,965 | $291,992 | $306,042 | $390,025 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6,829 | $5,891 | $8,272 | $7,634 |
| Total Curr. Assets | $336,138 | $385,604 | $433,708 | $462,355 |
| Property Plant & Equip (Net) | $1,350 | $1,607 | $1,862 | $2,116 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5,475 | $4,394 | $4,394 | $197 |
| Total NC Assets | $6,825 | $6,001 | $6,256 | $2,313 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $342,963 | $391,605 | $439,964 | $464,668 |
| Liabilities | – | – | – | – |
| Payables | $3,515 | $8,844 | $7,387 | $4,458 |
| Short-Term Debt | $832 | $821 | $811 | $800 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $15,828 | $10,454 | $13,549 | $13,345 |
| Total Curr. Liab. | $20,175 | $20,119 | $21,747 | $18,603 |
| LT Debt | $213 | $425 | $634 | $842 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6,795 | $6,645 | $6,499 | $6,356 |
| Total NC Liab. | $7,008 | $7,070 | $7,133 | $7,198 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,045 | $1,246 | $1,445 | $1,642 |
| Total Liabilities | $27,183 | $27,189 | $28,880 | $25,801 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $78 | $81 | $85 | $84 |
| Retained Earnings | -$477,702 | -$435,653 | -$398,492 | -$364,220 |
| AOCI | $238 | $37 | $118 | $233 |
| Other Equity | $793,166 | $799,951 | $809,373 | $802,770 |
| Total Equity | $315,780 | $364,416 | $411,084 | $438,867 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $342,963 | $391,605 | $439,964 | $464,668 |
| Net Debt | -$76,299 | -$86,475 | -$117,949 | -$63,054 |